Femasys Inc — Cash Flow (NASDAQ:FEMY) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities -7.93 M-10.73 M-11.28 M-19.44 M -19.58 M Cash from investing activities -306.87 K-407.48 K-143.92 K-847.76 K -544 K Cash from financing activities 29.7 M-681.64 K20.18 M2.03 M 17.08 M Free cash flow -8.24 M-11.14 M-11.42 M-20.29 M -20.12 M

Nachrichten

Femasys receives CPT code approval for infertility treatment

Femasys-Aktie steigt nach Ankündigung einer Vertriebspartnerschaft in der Schweiz

Femasys expands European presence with Swiss distribution deal

Femasys: NASDAQ verlängert Frist zur Erfüllung der Mindestkurspflicht um 180 Tage

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule

Femasys: Partnerschaft mit Refuah Health Center soll FemaSeed-Fertilitätsbehandlung ausweiten

Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232

Pharmacyte Biotech CEO Silverman buys $80k in shares

Femasys receives FDA clearance for FemVue Controlled diagnostic device

PharmaCyte-Aktie haussiert nach erfolgreichem Verkauf von Femasys-Beteiligung

PharmaCyte Biotech stock soars after successful Femasys stake sale